equity market growth and to serve the needs of the real economy worldwide. The most important achievement of the meeting was the adoption of a Guide to strengthen corporate governance through effective
respectively which is reflecting from the company’s policy to close the stores with operating loss as mentioned above. However, the company continues to closely monitor to reduce the food waste and for
growth in all major segments together with gross margin expansion. - Q1’20 Revenue from sales grew by 5.0% YoY, amounting to THB 6.7 billion, driven by the growth in all major segments particulary
stages of the outbreak of COVID 19, the Company formed a central committee to monitor and manage risks, as well as establishing working committees for all subsidiaries. These committees closely monitor and
6661 Fax: +662 661 6664 1 2019 IVL Performance Summary IVL registered volume growth of 18% in 2019 driven mainly by inorganic expansion. Industry-wide spreads declined to historical lows in 2019, leading
social exclusion and environmental degradation, which significantly impact sustainable development, inclusive growth, and the collective well-being and prosperity of economies, societies, people and the
containing the COVID-19, economic growth is forecasted to contract by -7.8%1; the lowest growth among ASEAN countries. In addition, a range of political issues are loading to an uncertain economic recovery
to monitor the situation closely in order to conduct the appropriate measures. For more details, please see section “COVID-19: Impacts and Response Plan” 1Q 2020 PERFORMANCE 1Q 2020 P&L SNAPSHOT AND
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
supply significant portion of our internal electricity use decreasing further operational expenses. 2. Outlook Economic growth accelerated in the third quarter from the near five-year low in the second